Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2025 Jul 18:2025.07.15.664917. [Version 1] doi: 10.1101/2025.07.15.664917

Structural Basis for HIV-1 Maturation Inhibition by PF-46396 Determined by MAS NMR

Roman Zadorozhnyi, Caitlin M Quinn, Kaneil K Zadrozny, Sherimay D Ablan, Brandon J Kennedy, Glenn P A Yap, Daniel Sanner, Christina Kraml, Eric O Freed, Barbie K Ganser-Pornillos, Owen Pornillos, Angela M Gronenborn, Tatyana Polenova
PMCID: PMC12338672  PMID: 40791438

ABSTRACT

Among the different types of HIV-1 maturation inhibitors, those that stabilize the junction between the capsid protein C-terminal domain (CA CTD ) and the spacer peptide 1 (SP1) within the immature Gag lattice are promising candidates for antiretroviral therapies. Here, we report the atomic- resolution structure of CA CTD -SP1 assemblies with the small-molecule maturation inhibitor PF- 46396 and the assembly cofactor inositol hexakisphosphate (IP6), determined by magic angle spinning (MAS) NMR spectroscopy. Our results reveal that although the two PF-46396 enantiomers exhibit distinct binding modes, they both possess similar anti-HIV potency. PF-46396 binding arrests IP6 dynamics in the six-helix bundle pore, and the two enantiomers induce unique IP6 orientations in the pore. Importantly, our data suggest the presence of monoanionic IP6 form IP6 in the complex. Our study establishes the structural basis for PF-46396 action and suggests a mechanistic model for drug resistance.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES